[The epidemiology of heart failure in Japan].
[The epidemiology of heart failure in Japan].
复制标题
日本心力衰竭的流行病学[J].
DOI：
--
复制
发表时间：
2003
期刊：
影响因子：
--
通讯作者：
A. Kitabatake
中科院分区：
文献类型：
--
作者：
H. Okamoto;A. Kitabatake
关于日本人群中心力衰竭预后和生存时间变化的流行病学数据非常有限。根据洋地黄的总销售额、处方率和心律失常的使用率估计，日本至少有100万患者患有心力衰竭。扩张型心肌病（DCM）是严重心力衰竭的主要原因。在过去的27年里，三个队列对应于三个不同的9年期间进行了调查。十年生存率逐步提高。患者年龄较大，受影响程度较轻，部分解释了生存率的提高。在ACE抑制剂和β受体阻滞剂治疗的亚组中，计算的10年生存率达到90%以上。
Very limited epidemiological data are available regarding the prognosis of heart failure and temporal changes in survival in a population-based setting in Japan. It is estimated from the total sales of digitalis, its prescription rate and usage ratio for arrhythmias that at least one million of patients suffer from heart failure in Japan. Dilated cardiomyopathy (DCM) is a major cause of severe heart failure. Over the past 27 years, three cohorts corresponding to three different periods of 9 years were investigated. Ten-year survivals were progressively improved. Patients were older and less severely affected, partly explaining the improvement in survival. In the subgroups treated with ACE inhibitors and beta blockers, calculated ten-year survival rate reached over 90%.